Schrodinger (NASDAQ:SDGR - Get Free Report)'s stock had its "sell (e+)" rating restated by analysts at Weiss Ratings in a research note issued to investors on Tuesday,Weiss Ratings reports.
SDGR has been the topic of a number of other research reports. Morgan Stanley dropped their price objective on Schrodinger from $28.00 to $19.00 and set an "equal weight" rating on the stock in a report on Monday, August 18th. KeyCorp cut their price target on shares of Schrodinger from $30.00 to $28.00 and set an "overweight" rating on the stock in a report on Wednesday, October 8th. Wall Street Zen downgraded shares of Schrodinger from a "hold" rating to a "sell" rating in a report on Saturday, October 4th. The Goldman Sachs Group assumed coverage on Schrodinger in a research report on Monday, September 29th. They issued a "neutral" rating and a $19.00 price target for the company. Finally, Barclays initiated coverage on Schrodinger in a research report on Thursday, August 14th. They issued an "overweight" rating and a $25.00 price target for the company. Four research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $26.29.
Get Our Latest Analysis on SDGR
Schrodinger Stock Up 0.1%
Shares of NASDAQ:SDGR traded up $0.02 during trading on Tuesday, reaching $19.72. 389,371 shares of the company traded hands, compared to its average volume of 1,140,760. The firm has a fifty day simple moving average of $19.56 and a 200 day simple moving average of $21.34. Schrodinger has a 1-year low of $16.60 and a 1-year high of $28.47. The firm has a market cap of $1.45 billion, a P/E ratio of -7.95 and a beta of 1.74.
Schrodinger (NASDAQ:SDGR - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.59) earnings per share for the quarter, topping the consensus estimate of ($0.83) by $0.24. Schrodinger had a negative return on equity of 45.70% and a negative net margin of 76.22%.The company had revenue of $54.76 million for the quarter, compared to analyst estimates of $52.03 million. During the same period in the prior year, the firm posted ($0.66) EPS. The business's revenue was up 15.7% compared to the same quarter last year. As a group, research analysts anticipate that Schrodinger will post -2.37 EPS for the current year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the business. PNC Financial Services Group Inc. boosted its holdings in Schrodinger by 29.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,956 shares of the company's stock valued at $58,000 after purchasing an additional 680 shares during the period. Bank of Montreal Can boosted its holdings in Schrodinger by 5.8% in the 2nd quarter. Bank of Montreal Can now owns 15,941 shares of the company's stock valued at $321,000 after purchasing an additional 879 shares during the period. Farther Finance Advisors LLC grew its position in Schrodinger by 347.4% during the second quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company's stock worth $26,000 after buying an additional 997 shares in the last quarter. Tema Etfs LLC grew its position in Schrodinger by 6.3% during the second quarter. Tema Etfs LLC now owns 17,493 shares of the company's stock worth $352,000 after buying an additional 1,036 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in Schrodinger by 8.2% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 14,343 shares of the company's stock worth $289,000 after buying an additional 1,082 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
About Schrodinger
(
Get Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Schrodinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.
While Schrodinger currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.